IQVIA

Astellas

Follow

Two decades of innovation Leaders from Yamanouchi and Fujisawa shake hands, marking the 2005 merger that formed Astellas and shaped a patient-first global strategy. In April 2025, Astellas celebrated our 20th Anniversary as a company. Astellas was established in April 2005 through the merger of two companies – Yamanouchi Pharmaceutical (founded in 1923) and Fujisawa Pharmaceutical (founded in 1894). The merger brought together Yamanouchi's strengths in urological medications and chemical synthesis and Fujisawa's excellence in the transplant/immunology area and fermentation technology, forming an ideal complementary partnership. Today, Astellas has more than 13,500 employees around the world. Since our founding, we have reached more than 172 million patients in 103 countries and areas with therapies that have helped to transform their lives. The story of our name The name ‘Astellas’ expresses the idea of ‘aspired stars’ and ‘advanced stars’ and derives from the Latin word ‘stella,’ Greek ‘aster,’ and English ‘stellar,’ which all refer to ‘stars.’ The name is also connected to the Japanese phrase, ‘Make tomorrow shine.’

EPHICACY

Follow

Ephicacy was formed in 2005 in New Jersey, US, with an objective of being a niche provider of data analytics services in supporting research and clinical trial activities in life sciences industry. Technology services in healthcare analytics is also an integral part of our offerings. Ephicacy’s presence in Bangalore, India was established in 2009. Established as a Centre of Excellence (CoE), the intent is to tap locally available talent and serve the needs of customers worldwide. Our focus on hiring and nurturing talent through well-established learning and development processes have led to the creation of a competent and committed team. The COE in India is delivery driven with well-documented and practised SOPs. We are also certified ISO 9001:2015 and an ISO 27001:2013 company. Our global delivery organization comprises of a well-knit team of experienced biostatisticians, clinical programmers, data managers, and domain experts to meet the ever-growing needs of clinical analytics leaders. Our technology service includes expertise in product design, web-based and cloud technologies with special interest in healthcare domain. Ephicacy has stepped up to address the paucity of qualified resources in these functional areas and is able to rapidly fulfil the needs of customers using flexible and bespoke business engagement models. Our highly qualified leadership team handpicks resources from our pool of qualified professionals to ensure customer projects are well resourced. Today, Ephicacy has proven to be a pioneer and continues to be a forerunner in providing ACCURATE, ON TIME AND SECURE solutions for pharmaceuticals, biotechnology, medical research, and healthcare organizations worldwide.